Sign In
Last checked at 
30 Jan 2023 07:00
FOR RELEASE ON | 30 January 2023 |
IP Group plc - Statement re press speculation
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops world-changing science and technology businesses, notes the press speculation regarding portfolio company Istesso Ltd. The Group is aware of exploratory discussions around a potential business combination which have now been terminated.
For more information, please contact:
IP Group plc | www.ipgroupplc.com |
Liz Vaughan-Adams, Communications | +44 (0) 20 7444 0062/+44 (0) 7967 312125 |
Numis | |
James Black | +44 (0) 20 7260 1000 |
Portland | |
Vic Wallin | +44 (0) 7973 823 119 |
Alex Donaldson | +44 (0) 7516 729 702 |
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
Follow the stocks
